Stay updated on Dapagliflozin Effects on Heart in Diabetes Clinical Trial
Sign up to get notified when there's something new on the Dapagliflozin Effects on Heart in Diabetes Clinical Trial page.

Latest updates to the Dapagliflozin Effects on Heart in Diabetes Clinical Trial page
- Check6 days agoChange DetectedPage shows a revision reference updated from v3.3.1 to v3.3.2; there are no visible changes to study details or layout. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check13 days agoChange DetectedRevision label updated from v3.2.0 to v3.3.1. No substantive study information or interactive elements appear to be affected.SummaryDifference0.1%

- Check21 days agoChange DetectedRemoved the government funding lapse notice on the page; it was an administrative banner unrelated to the study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check35 days agoChange DetectedThe screenshots show only minor layout and formatting adjustments on the study page, with no change to the core study content such as the study purpose, eligibility criteria, endpoints, or listed locations. No new data or changes to the DAPAgliflozin (DAPACARD) study details are evident. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check64 days agoChange DetectedMajor update: page now includes a government funding status notice and indicates version 3.2.0, replacing the previous 3.1.0.SummaryDifference4%

- Check71 days agoChange DetectedAdded new version label v3.1.0 and removed multiple drug-safety topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs, plus an older revision v3.0.2). The page now contains less high-importance content on drug quality and safety.SummaryDifference0.4%

Stay in the know with updates to Dapagliflozin Effects on Heart in Diabetes Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dapagliflozin Effects on Heart in Diabetes Clinical Trial page.